Medicine & Life Sciences
Retinal Vein Occlusion
100%
Macular Edema
90%
Vascular Endothelial Growth Factor A
67%
Visual Acuity
40%
aflibercept
34%
pegaptanib
25%
Ranibizumab
20%
Injections
17%
Bevacizumab
17%
Israel
17%
Randomized Controlled Trials
15%
France
14%
Eye
14%
Confidence Intervals
13%
Germany
13%
Safety
13%
Ocular Vision
13%
Therapeutics
12%
Latvia
12%
Meta-Analysis
11%
Clinical Trials
10%
Odds Ratio
10%
Hungary
9%
Argentina
9%
Databases
9%
Austria
9%
Republic of Korea
9%
Intravitreal Injections
9%
Retinal Vessels
9%
Singapore
9%
Norway
8%
Data Accuracy
8%
Diabetic Retinopathy
8%
Congresses
7%
Sweden
7%
Health
7%
Spain
7%
Italy
7%
Canada
7%
Libraries
6%
India
6%
Patient Selection
6%
MEDLINE
6%
Multicenter Studies
6%
Nursing
6%
Japan
6%
Adrenal Cortex Hormones
6%
Language
6%
Registries
6%
Economics
6%
Data Analysis
5%
Quality of Life
5%
Incidence
3%